| Original document(53 pages) 中文版 |
This invention relates to PKC inhibitors which are able to selectively inhibit e.g. alpha, beta and optionally theta isoforms of PKC, and their use in particular in transplantation. |
Application Number
申请号 |
200580002684 |
Application Date
申请日 |
2005.01.19 |
| Title 名称 |
Indolylmaleimide derivatives as PKC inhibitors |
Publication Number
公开号 |
1910173 |
Publication Date
公开日 |
2007.02.07 |
| Approval Pub. Date |
|
Granted Pub. Date |
|
| International Classification 分类号 |
C07D403/04;C07D401/14;C07D213/00;C07D209/00;C07D207/00 |
Applicant(s) Name
申请人 |
Novartis AG |
| Address 地址 |
|
| Inventor(s) Name 发明人 |
Van Eis Maurice;Von Matt Peter;Wagner Juergen;Evenou Jean-pierre;Schuler Walter |
| Attorney & Agent 代理人 |
huang gesheng gui yongliang |
| More information 更 多 信 息 |
|
| Related patents information |
|
|
|
|
|
|